To understand how this early-stage company has won awards for science and innovation while winning customers like Janssen, Mosaic, and Harvard,
you have to think differently.
The Microbiome is the hottest frontier in personalized medicine. Every major pharma, tech, food and academic organization is racing to find a model that works. Our goal is to develop tools that will accelerate the entire industry.
COLLECT | Kits & Samples
The BioCollector Kit™ is a patented system for simplified, collection of quality, standardized, whole stool samples. Used by customers like Harvard’s Dana-Farber Cancer Insitute, The University of Chicago, and AXIAL Therapeutics this system provides high quality samples for use in multi-comics analysis from genomics to metabolomics to isolation and culturing.
Quality samples are critical for more robust data analysis and discovery.
Old models won't work for the microbiome.
If you only look narrowly You may miss the full picture.
CONNECT | Data & Sample Bank
The BioCollective is analyzing the microbiome with unprecedented depth and scope. Through their bank of population samples from age 1-102, and diversity of health, lifestyle and microbiome metadata The BioCollective is able to analyze patterns across health and disease states, leading to a multitude of discoveries such as: biomarkers, microbial culturing, improved strain characterization, and strain bank development for use in probiotic therapeutics and other applications.
Read: CSO Dr. Raul Cano - Publications
" What the BioCollective has accomplished is breathtaking: they are pushing the boundaries of science and sequencing to make connections that will change food and healthcare for the better. ”
Linda Avery / Co-Founder 23 and Me
An Innovation Engine
Our proprietary BioFlux™ Metabolic Model provides a lens for product development across pharma, food, home care products, and more. BioFlux’s in silico analysis of microbial community dynamics within the gut microbiome offers insights for novel formulation.
Read Dr. Naseer Sangwan’s research on microbial ecology
Learn how BioFlux is accelerating product
development, including The BioCollective’s debut formulation
Sugar Buster Biotica.
CORRECT | Probiotics
Sugar Buster Biotica is scientifically designed to restore function and balance. Through The BioCollective’s rapid advancements in complex modeling, metagenomic sequencing and extensive probiotic strain library scientifically designed and validated formulations are now within reach.
Sugar Buster Biotica is available now
When Martha Carlin’s husband John was diagnosed with early-onset Parkinson’s Disease in 2002, she had no time to just wait and hope for a cure. She began researching everything she could... and everything she found pointed to the microbiome — hidden in our guts and often called the body’s second brain. Martha knew she had to pull together a team to think differently, and The BioCollective was born. Since then, the BioCollective team has proceeded to unleash the power of the microbiome through industry-leading methods to easily Collect samples, harnessing new metagenomic data and proprietary software to Connect patterns that emerge, and produced a novel probiotic (with more in the pipeline) to Correct balance in the gut.
And 16 years later, John is beating the odds, boxing, cycling, ice-climbing, and leading Parkinson’s support groups. The BioCollective is here to help others the way it has helped John.
View : Martha at TEDx Boulder & The White House
“Before we can make correlations of microorganisms with a condition, we need to know that the microbiome we have is reflective of reality.”
Dr. Raul Cano
Nature / Read Full Article
Our gut is our internal pharmacy where food and drinks are transformed into vitamins, hormones, neurotransmitters and enzymes. In order for us to be healthy we must restore the function and balance of this vital organ.
CEO Martha Carlin
Tomorrow Edition / Read Full Article
I understood Parkinson’s as a systemic problem; these are systemic conditions and require that same systems approach from my business career to fully understand what’s going on. So I started applying my systems thinking to the problem.
CEO Martha Carlin
MicrobiomeTimes / Read Full Article